Your trusted destination for CME, CPD & Medical Education across the Middle East.
Sheikh Shakhbout Medical City, Abu Dhabi, UAE
Dr. Marleine Pierre Bejjani Moukarzel, PharmD, BCNSP, BCPS, CPHQ, CMQ is a senior pharmacy leader in the United Arab Emirates and currently serves as Pharmacy Director at Sheikh Shakhbout Medical City (SSMC), Abu Dhabi. She has more than 27 years of hospital pharmacy experience and has held progressively senior pharmacy-management and leadership responsibilities in the UAE. SSMC identifies her as the Pharmacy Director and highlights her leadership in medication-management accreditation, controlled-drug automation, patient-experience initiatives and pharmacy service innovation.
Dr. Marleine Bejjani Moukarzel is currently Pharmacy Director at Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, UAE. She is also part of the leadership team of SSMC's Health Sciences Education Centre, where she is listed as the lead for Pharmacy.
Her role encompasses strategic and operational leadership of pharmacy services within one of Abu Dhabi's major tertiary hospitals. Her professional portfolio covers pharmacy operations, medication management, quality and patient safety, clinical pharmacy, pharmacy technology, formulary management and the development of innovative pharmacy services.
Professional programmes published in 2026 identify Dr. Bejjani Moukarzel with the following credentials:
These credentials demonstrate a broad professional background combining clinical pharmacotherapy, nutrition support, healthcare quality and management.
I could not find an authoritative public source specifying the university and year of her PharmD qualification, so those details should not be added without further verification.
Prior to her leadership role at SSMC, Dr. Bejjani Moukarzel spent many years at Mafraq Hospital in Abu Dhabi. SSMC states that she has more than 27 years of hospital experience, while an SSMC pharmacy-history presentation records her Mafraq Hospital period as 1983–2019, followed by her SSMC career from 2019 onward.
During her earlier career she progressed through senior pharmacy responsibilities, including serving as a Senior Clinical Pharmacist at Mafraq Hospital. A 2019 medication-safety conference programme lists her in that role and shows her presenting on “Common Drugs. Uncommon Indications.”
Her long period in hospital pharmacy provided extensive experience in clinical pharmacy practice, medication management, pharmacy operations and multidisciplinary healthcare delivery.
Dr. Bejjani Moukarzel joined Sheikh Shakhbout Medical City in 2019, initially serving as a Pharmacy Manager before progressing to Pharmacy Director. SSMC's official biography highlights several major achievements from her leadership.
Among her documented achievements are:
These initiatives illustrate her focus on combining pharmacy safety and operational efficiency with patient-centered service delivery.
Dr. Bejjani Moukarzel has been an active advocate of technology-enabled pharmacy practice. At SSMC pharmacy symposia she has spoken about the use of technology, artificial intelligence and innovative pharmacy systems.
At the 3rd SSMC Pharmacy Symposium, she presented “Future of AI in Pharmacy” and also delivered a presentation on “Optimising the Potential of Biosimilars; Cost-effectiveness and Regulation Aspects.”
At the 2nd SSMC Pharmacy Symposium, she served as the Pharmacy Director, delivered the opening message and presented a session on revenue-cycle-management success in pharmacy.
Her work therefore extends beyond traditional pharmacy management into digital transformation, AI, healthcare economics, medication-use optimization and new models of pharmacy service delivery.
Although her current role is primarily leadership-oriented, Dr. Bejjani Moukarzel has a substantial clinical-pharmacy background. Her BCPS credential reflects formal specialization in pharmacotherapy, while her BCNSP certification reflects additional expertise in nutrition-support pharmacy.
Her professional activities have included medication management, formulary and therapeutic decision-making, medication safety, clinical pharmacy services and the development of systems designed to optimize pharmaceutical care.
Her involvement in pharmacy quality and accreditation also reflects her interest in establishing safe, standardized medication-use systems across the hospital.
Dr. Bejjani Moukarzel has contributed to research in antimicrobial stewardship, particularly in the UAE hospital setting.
She was a member of the multidisciplinary study group behind the research article “Impact of antimicrobial stewardship interventions on days of therapy and guideline adherence: A comparative point-prevalence survey assessment.” The study included pharmacy and infectious-disease professionals from SSMC and evaluated the impact of antimicrobial-stewardship interventions on antibiotic utilization and adherence to clinical guidelines.
The publication lists her affiliation as the Department of Pharmacy, Sheikh Shakhbout Medical City in partnership with Mayo Clinic, Abu Dhabi, UAE.
This research contributes to her broader professional profile in medication optimization, antimicrobial stewardship, clinical quality and patient safety.
Dr. Bejjani Moukarzel is also involved in health-policy and pharmaceutical research.
In 2025, she was a co-author of the peer-reviewed article:
“Driving the future of value-based healthcare in the Gulf Cooperation Council: a roadmap for achieving sustainable access to specialty pharmaceuticals.”
The article was published in Frontiers in Public Health and examines challenges and opportunities surrounding access to high-cost specialty pharmaceuticals across GCC healthcare systems. Her affiliation is listed as the Department of Pharmacy, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.
Her participation in this work demonstrates an interest extending beyond hospital pharmacy operations into value-based healthcare, pharmaceutical access, health economics, specialty medicines and GCC health-policy development.
Dr. Bejjani Moukarzel is regularly invited to participate in pharmacy and healthcare conferences as a speaker, moderator, committee member and pharmacy-leadership expert.
She has participated in programmes covering:
In 2026, she was also listed as a speaker/faculty member for specialist pharmacy programmes with her full credentials PharmD, BCNSP, BCPS, CPHQ and CMQ.
Dr. Marleine Pierre Bejjani is the Conference Chair and Pharmacy Director for the 4th SSMC Pharmacy Conference, scheduled for 3 October 2026 at Sheikh Shakhbout Medical City in Abu Dhabi. The conference theme is “Pharmacy at the Frontlines of Innovation and Health Equity.”
Her responsibilities include providing leadership for the conference and representing the pharmacy department at the event.
She is scheduled to deliver the Message from the Pharmacy Director during the symposium opening. She will also participate in the Youth and the Future of Pharmacy session in a debate titled:
“AI in Medication Management: Promise and Pitfalls.”
She is also scheduled to deliver the closing remarks for the conference.
Her documented areas of expertise include:
Dr. Marleine Pierre Bejjani Moukarzel has developed a more than 27-year career in hospital pharmacy, progressing from clinical and senior pharmacy responsibilities at Mafraq Hospital to pharmacy leadership at Sheikh Shakhbout Medical City. Her current role combines clinical-pharmacy knowledge with healthcare quality, operational leadership, technology adoption and patient-service innovation.
At SSMC, she has played an important role in advancing pharmacy services through controlled-drug automation, JCI medication-management accreditation, digital patient counselling, home-delivery services and technology-enabled pharmacy initiatives.
Her research and professional activities additionally demonstrate involvement in antimicrobial stewardship and pharmaceutical-policy research, including work on sustainable access to specialty pharmaceuticals across the GCC.
Her combination of PharmD, BCNSP, BCPS, CPHQ and CMQ credentials, extensive hospital experience and current Pharmacy Director role places her among the senior pharmacy leaders contributing to the development of pharmacy practice and healthcare quality in the UAE.
| FieldDetails | |
| Full name | Marleine Pierre Bejjani Moukarzel |
| Current institution | Sheikh Shakhbout Medical City, Abu Dhabi |
| Current position | Pharmacy Director |
| Experience | 27+ years of hospital experience |
| Previous institution | Mafraq Hospital, Abu Dhabi |
| Current credentials | PharmD, BCNSP, BCPS, CPHQ, CMQ |
| Clinical expertise | Pharmacotherapy, nutrition support, medication management |
| Leadership expertise | Pharmacy operations, quality, accreditation, innovation |
| Research areas | Antimicrobial stewardship, specialty pharmaceuticals, value-based healthcare |
| 2026 role | Chair, 4th SSMC Pharmacy Conference |
| 2026 conference topic | “AI in Medication Management: Promise and Pitfalls” |
| Professional interests | AI, pharmacy technology, biosimilars, medication safety, healthcare quality |
Verification note: The exact university and year of her PharmD qualification, as well as a complete chronological employment history, were not available from sufficiently authoritative public sources. I have therefore excluded those details rather than attributing information from potentially unrelated profiles.

SSMC Training Academy
SSMC Training Academy